Please login to the form below

Not currently logged in
Email:
Password:

anti-infectives

This page shows the latest anti-infectives news and features for those working in and with pharma, biotech and healthcare.

UK unveils new antibiotic buying plan, pharma incentives

UK unveils new antibiotic buying plan, pharma incentives

The answer is to develop a new economic model for antibiotic development that doesn’t tie revenue to volume, as new anti-infectives generally need to be conserved.

Latest news

More from news
Approximately 4 fully matching, plus 50 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    An immunologist with over two decades’ experience in anti-infectives research and drug development, Deborah set up Novabiotic Pharmaceuticals to discover and develop the next generation of treatments.

  • Deal Watch May 2016 Deal Watch May 2016

    Not only but also…. To close this month a recent report from the UK government expresses concerns about the lack of investment in anti-infectives R&D.

  • Another lost decade for research? Another lost decade for research?

    use but new classes of antibiotics - as well as non-antibiotic approaches such as other anti-infective treatments. ... Over the past 10 years the number of patent families filed in the antibiotics and anti-infectives field has remained stable, with

  • Pharma deals in June 2015 Pharma deals in June 2015

    CNS, diabetes, respiratory, vaccines and anti-infectives, oncology and autoimmune diseases. ... The consequences of acquisitions. One of the consequences of M&A is the need to assess a newly combined portfolio for potential anti-competitive issues.

  • Pharma deals in February 2015 Pharma deals in February 2015

    Hospira's broad generic sterile injectables business covers acute care and oncology which compliments Pfizer's branded sterile injectables covering anti-infectives, anti-inflammatories and cytotoxics.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    Prior to that, McDevitt held positions with increasing responsibility within worldwide business development at GSK Ventures and Anti-Infectives Discovery.

  • Nabriva Therapeutics appoints new chief commercial officer Nabriva Therapeutics appoints new chief commercial officer

    Lavino joins the Austrian clinical-stage biopharma firm from Merck &Co (MSD), bringing nearly two decades of pharmaceutical sales and marketing experience with expertise in anti-infective medications. ... Prior to serving MSD as its acting vice president,

  • Cidara Therapeutics makes senior appointments Cidara Therapeutics makes senior appointments

    Prior to BMS, Daruwala spent 18 years at Merck in a range of US and global commercial leadership roles in areas including anti-inflammatory products, business development and sales management. ... Cidara focuses on the discovery, development and

  • Xellia forms scientific advisory board Xellia forms scientific advisory board

    Will further progress on innovative anti-infectives. Xellia Pharmaceuticals, who have a focus on anti-infective treatments, has announced the formation of a new scientific advisory board.

  • Melinta names chief medical officer Melinta names chief medical officer

    She has prior experience in developing anti-infectives, including Cubicin (daptomycin) during her time at Novartis, where she served as VP and global programme head for the company's immunology and ... At Pharmacia, she worked on the anti-infective Zyvox

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • Healthcircle

    Rx &Medical Devices. Oncology. Haematology. Rheumatology. Anti-infectives. Anti-virals. Cardiovascular. Respiratory. Endocrinology. ... Low-energy. Cough &Cold. Anti-infectives. Smoking Cessation. Eczema &Dry Skin. Vitamins &Minerals.

  • SENIOR PHARMA MARKETER JOINS CELLO HEALTH CONSULTING

    Most recently, Jon was  working at Astellas Europe. He joined the company as Director of Early Phase Commercial Development, before heading up Astellas’ European marketing team for Anti-Infectives.  Prior to

  • Hayward Medical Communications

    Allergic Disorders. Anaesthetics. Anti-infectives. Cancer/oncology. Cardiovascular. Central nervous system (CNS). Contraception.

  • SEVEN STONES

    Branding. Digital and tech solutions. Exercise co-prescription. Workplace wellbeing. Experience. Anti-infectives, cardiovascular, contrast media, dermatology, diabetes,  diagnostics, gastroenterology, gene therapy, health and fitness,  hepatology,

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics